PDT Partners’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.19M | Hold |
12,895
| – | – | 0.37% | 86 |
|
|
2025
Q4 | $7.24M | Sell |
12,895
-3,029
| -19% | -$1.72M | 0.47% | 46 |
|
|
2025
Q3 | $8.19M | Sell |
15,924
-1,370
| -8% | -$598K | 0.52% | 39 |
|
|
2025
Q2 | $5.43M | Buy |
17,294
+16,251
| +1,558% | +$4.88M | 0.31% | 90 |
|
|
2025
Q1 | $318K | Sell |
1,043
-4,575
| -81% | -$1.54M | 0.02% | 602 |
|
|
2024
Q4 | $1.87M | Sell |
5,618
-3,165
| -36% | -$1.07M | 0.17% | 224 |
|
|
2024
Q3 | $2.93M | Sell |
8,783
-8,234
| -48% | -$3.13M | 0.26% | 122 |
|
|
2024
Q2 | $7.01M | Sell |
17,017
-3,992
| -19% | -$1.58M | 0.66% | 4 |
|
|
2024
Q1 | $8.49M | Sell |
21,009
-18
| -0.1% | -$6.33K | 0.8% | 5 |
|
|
2023
Q4 | $6.45M | Sell |
21,027
-154
| -0.7% | -$41.6K | 0.71% | 6 |
|
|
2023
Q3 | $5.13M | Buy |
21,181
+1,975
| +10% | +$505K | 0.65% | 5 |
|
|
2023
Q2 | $4.61M | Buy |
19,206
+7,101
| +59% | +$1.48M | 0.63% | 15 |
|
|
2023
Q1 | $2.28M | Buy |
12,105
+5,291
| +78% | +$1.09M | 0.31% | 108 |
|
|
2022
Q4 | $1.45M | Sell |
6,814
-8,625
| -56% | -$1.72M | 0.23% | 143 |
|
|
2022
Q3 | $2.43M | Sell |
15,439
-7,101
| -32% | -$1.13M | 0.37% | 48 |
|
|
2022
Q2 | $3.37M | Buy |
22,540
+4,446
| +25% | +$644K | 0.3% | 66 |
|
|
2022
Q1 | $2.96M | Sell |
18,094
-3,289
| -15% | -$542K | 0.25% | 99 |
|
|
2021
Q4 | $4.65M | Sell |
21,383
-6,510
| -23% | -$1.36M | 0.35% | 66 |
|
|
2021
Q3 | $5.28M | Buy |
27,893
+3,967
| +17% | +$724K | 0.38% | 48 |
|
|
2021
Q2 | $4.23M | Sell |
23,926
-4,876
| -17% | -$842K | 0.28% | 163 |
|
|
2021
Q1 | $4.72M | Sell |
28,802
-16
| -0.1% | -$2.45K | 0.34% | 62 |
|
|
2020
Q4 | $4.01M | Sell |
28,818
-13,688
| -32% | -$1.73M | 0.27% | 172 |
|
|
2020
Q3 | $4.75M | Buy |
42,506
+6,566
| +18% | +$759K | 0.31% | 136 |
|
|
2020
Q2 | $3.34M | Sell |
35,940
-7,460
| -17% | -$635K | 0.23% | 155 |
|
|
2020
Q1 | $3.19M | Buy |
+43,400
| New | +$3.77M | 0.25% | 121 |
|
|
2019
Q1 | – | Sell |
-47,017
| Closed | -$2.49M | – | 475 |
|
|
2018
Q4 | $2.49M | Sell |
47,017
-57,248
| -55% | -$3.14M | 0.14% | 168 |
|
|
2018
Q3 | $6.25M | Buy |
104,265
+36,365
| +54% | +$1.99M | 0.26% | 133 |
|
|
2018
Q2 | $2.92M | Buy |
67,900
+12,000
| +21% | +$485K | 0.11% | 208 |
|
|
2018
Q1 | $1.95M | Buy |
+55,900
| New | +$2.04M | 0.07% | 276 |
|
Other funds holding MEDP
VPM
VCM
WA
PDT Partners's MEDP Position: Q1 2026 in Review
PDT Partners held its Medpace (MEDP) position steady in Q1 2026 at 12,895 shares worth $6.19M. The position accounts for 0.37% of the portfolio, ranked #86.
PDT Partners first reported a position in MEDP in Q1 2018 and has held it in 29 quarters since. The position peaked at $8.49M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- PDT Partners held 12,895 shares of Medpace worth $6.19M as of Q1 2026.
- PDT Partners left its Medpace share count unchanged in Q1 2026.
- Medpace made up 0.37% of PDT Partners's portfolio in Q1 2026, its #86 holding.
- PDT Partners first reported a position in Medpace in Q1 2018 and has held it in 29 quarters since.
- PDT Partners's Medpace position peaked at $8.49M in Q1 2024.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.